Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14
Closed -$372 67
2025
Q4
$372 Buy
+14
New +$380 ﹤0.01% 86
2025
Q3
Sell
-14
Closed -$587 62
2025
Q2
$587 Buy
+14
New +$506 ﹤0.01% 90
2025
Q1
Sell
-14
Closed -$484 81
2024
Q4
$484 Hold
14
﹤0.01% 91
2024
Q3
$322 Hold
14
﹤0.01% 72
2024
Q2
$368 Hold
14
﹤0.01% 64
2024
Q1
$305 Hold
14
﹤0.01% 64
2023
Q4
$291 Hold
14
﹤0.01% 65
2023
Q3
$211 Hold
14
﹤0.01% 80
2023
Q2
$186 Hold
14
﹤0.01% 56
2023
Q1
$207 Hold
14
﹤0.01% 55
2022
Q4
$156 Hold
14
﹤0.01% 56
2022
Q3
$116 Hold
14
﹤0.01% 54
2022
Q2
$137 Hold
14
﹤0.01% 54
2022
Q1
$0 Hold
14
﹤0.01% 54
2021
Q4
$0 Buy
+14
New +$302 ﹤0.01% 52

Other funds holding KD

Family CFO's KD Position: Q1 2026 in Review

Family CFO sold out of Kyndryl (KD) in Q1 2026, closing a stake of 14 shares — an estimated $372 sold.

Family CFO first reported a position in KD in Q4 2021 and held it in 15 quarters. The position peaked at $587 in Q2 2025. 662 funds tracked by Wall St. Rank hold KD as of Q1 2026.

  • Family CFO reported no remaining Kyndryl position as of Q1 2026 after selling out during the quarter.
  • Family CFO sold 14 Kyndryl shares in Q1 2026, an estimated $372.
  • Family CFO first reported a position in Kyndryl in Q4 2021 and held it in 15 quarters.
  • Family CFO's Kyndryl position peaked at $587 in Q2 2025.
  • 662 funds tracked by Wall St. Rank held Kyndryl as of Q1 2026.

Based on Family CFO's 13F filing for Q1 2026, filed 28 Apr 2026.